Isolated hepatic perfusion with high-dose melphalan for the treatment of colorectal metastasis confined to the liver
British journal of surgery2003Vol. 90(11), pp. 1391–1397
Citations Over TimeTop 11% of 2003 papers
Joost Rothbarth, Milan E. J. Pijl, Alexander L. Vahrmeijer, H.H. Hartgrink, Fred G. J. Tijl, Peter J.K. Kuppen, Rob A.�E.�M. Tollenaar, C.J.H. van de Velde
Abstract
IHP for irresectable colorectal metastases confined to the liver resulted in good response rates and long-term survival in a selected group of patients.
Related Papers
- → Randomized Multicenter Trial of Hyperthermic Isolated Limb Perfusion With Melphalan Alone Compared With Melphalan Plus Tumor Necrosis Factor: American College of Surgeons Oncology Group Trial Z0020(2006)221 cited
- → Melphalan uptake, hyperthermic synergism and drug resistance in a human cell culture model for the isolated limb perfusion of melanoma(1994)45 cited
- → Factors influencing the chemosensitization of melphalan by misonidazole(1985)20 cited
- [Conservative therapy for retinoblastoma--effect of melphalan on in vitro electroretinogram].(1994)